APP and Alzheimer disease: Using the APP/PS1 AD mouse model, it has been shown that oral administration of methanol extract from leaves of MO (400 mg/kg/day for 4 months) attenuates the AD-related anxiety-like behavior and hyperactivity and cognitive, learning, and memory impairments.